// App-Quantinova.ai

1378 : Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach

Researchers

Presenter

  • Roger Belizaire

Principal Investigators

  • Olga Pozdnyakova

  • Daniel J DeAngelo

  • David M. Dorfman

  • Betty Li

  • MTASCP

  • Karry Charest

  • Richard M Stone

  • Martha Wadleigh

  • David P. Steensma

  • Gabriela Motyckova

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Department of Medicine, Brigham and Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved